Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oric Pharmaceuticals Inc 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 USA

www.oricpharma.com Employees: 115 P: 650-388-5600

Sector:

Medical

Description:

ORIC Pharmaceuticals Inc. is a clinical stage oncology company. It is focused on developing treatments which address mechanisms of therapeutic resistance. The company's product candidate consists of ORIC-101 and ORIC-533 which are in clinical stage. ORIC Pharmaceuticals Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,081,992
Enterprise Value, $K 1,022,582
Shares Outstanding, K 97,389
Float, K 90,747
% Float 93.18%
Short Interest, K 21,646
Short Float 22.23%
Days to Cover 12.79
Short Volume Ratio 0.87
% of Insider Shareholders 6.82%
% of Institutional Shareholders 95.05%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -127,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -32,590 K
EBIT, $ -148,020 K
EBITDA, $ -155,020 K

Growth:

1-Year Return 48.73%
3-Year Return 151.36%
5-Year Return -65.71%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/13/25
Next Earnings Date 02/24/26 [--]
Earnings Per Share ttm -1.73
EPS Growth vs. Prev Qtr 29.79%
EPS Growth vs. Prev Year 32.65%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ORIC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -45.33%
Return-on-Assets % -41.78%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.70
Book Value/Share 4.19
Interest Coverage -3.44
60-Month Beta 1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar